Alexion Pharmaceuticals Inc.

Looking ahead to 2025, industry leaders shared their insights into the key trends and topics they expect to see. Click on topic headings to read executive predictions. The insights in this article hav

It was Groundhog Day on 2 February. That week, any pharmaceutical groundhogs would have emerged from their burrows, glanced at the shadows of tariffs, a global trade war and weak Chinese demand and sc

“By 2025, clinical trials will undergo transformative advancements, driven by innovation, patient-centricity, and regulatory evolution.” So said Scott Schliebner , vice president and global head, dru

Some seven months after acquiring Canada’s Fusion Pharmaceuticals , AstraZeneca is expanding its footprint in the country with a fresh investment of C$820m ($570m). The investment, which will create